Market Overview

Stocks Hitting 52-Week Highs

Morning Market Movers
Benzinga's Top Pre-Market Gainers
FDA Panel Seen As Bad For BioMarin, Good For Sarepta (Investor's Business Daily)
Related SRDX
SurModics Receives FDA IDE Approval for Early Feasibility Study of the SurVeil™ Drug-Coated Balloon
Top 4 Stocks In The Diagnostic Substances Industry With The Lowest PEG Ratio

Sarepta Therapeutics (NASDAQ: SRPT) shares jumped 106.80% to create a new 52-week high of $31.00. Sarepta Therapeutics reported that treatment with its eteplirsen met its primary endpoint in a Phase IIb extension trial in Duchenne muscular dystrophy patients.

SurModics (NASDAQ: SRDX) shares gained 0.42% to touch a new 52-week high of $21.48. SurModics shares have surged 133.77% over the past 52 weeks, while the S&P 500 index has gained 28.63% in the same period.

Rockville Financial (NASDAQ: RCKB) shares rose 1.02% to create a new 52-week high of $12.83. Rockville Financial is estimated to report its Q3 results on October 25.

Ocwen Financial (NYSE: OCN) shares gained 15.16% to create a new 52-week high of $33.35. Ocwen Financial announced its plans to acquire Homeward Residential Holdings from WL Ross & Co LLC.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers


Related Articles (RCKB + OCN)

Get Benzinga's Newsletters